Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13371
Abstract: The identification of the high‐efficiency and non‐invasive biomarkers for hepatocellular carcinoma (HCC) detection is urgently needed. This study aims to screen out potential autoantibodies to tumor‐associated antigens (TAAbs) and to assess their diagnostic value for…
read more here.
Keywords:
hepatocellular carcinoma;
proteome microarray;
associated antigens;
autoantibodies tumor ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5739
Abstract: Cross‐lineage expression of the myeloid‐associated antigens CD13/CD33 is common in adult B‐lymphoblastic leukemia (B‐ALL) patients, yet its prognostic value is still controversial.
read more here.
Keywords:
expression myeloid;
lineage expression;
associated antigens;
antigens cd13 ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Hepatology"
DOI: 10.1002/hep.31502
Abstract: There are few treatment options for advanced-stage hepatocellular carcinoma (HCC). Targeting tumor-associated antigens (TAAs) for HCC immunotherapy has been tested clinically for many years with limited success. Recent advances in applying mutated tumor-specific neoantigens as…
read more here.
Keywords:
hepatocellular carcinoma;
immunotherapy;
targeting tumor;
tumor associated ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "Cell Reports"
DOI: 10.1016/j.celrep.2018.06.038
Abstract: Summary Conventional type 1 DCs (cDC1s) excel at cross-presentation of dead cell-associated antigens partly because they express DNGR-1, a receptor that recognizes exposed actin filaments on dead cells. In vitro polymerized F-actin can be used…
read more here.
Keywords:
dngr;
cell associated;
associated antigens;
cross presentation ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "International journal of biological macromolecules"
DOI: 10.1016/j.ijbiomac.2019.12.250
Abstract: Immunotherapies for cancer treatment constitute promising avenues to fight this global health issue. Algae can be used as both biofactories and delivery vehicles of vaccines; having low cost, fast growth, enhanced safety, and adjuvant effects…
read more here.
Keywords:
protein;
tumor associated;
bcb protein;
expression algae ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Seminars in immunology"
DOI: 10.1016/j.smim.2020.101394
Abstract: Immune responses to a large number of mutated and non-mutated tumor antigens have been studied in an attempt to unravel the highly complex immune response to cancer. Better understanding of both the effectors and the…
read more here.
Keywords:
tumor associated;
antigens taa;
cancer;
associated antigens ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead224
Abstract: OBJECTIVES To explore the relationship of tumor-associated antigens (TAAs) with the clinical manifestations and serological markers of systemic lupus erythematosus (SLE). METHODS This was a retrospective study. Clinical data of SLE patients were extracted from…
read more here.
Keywords:
sle;
positivity;
clinical manifestations;
associated antigens ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "mBio"
DOI: 10.1128/mbio.03852-21
Abstract: In this study, we demonstrated that it is possible to tolerize immune cells to potentially dampen the autoreactive proinflammatory immune response against Guillain-Barré syndrome (GBS)-associated antigens. The innate immune response functions to arm the host…
read more here.
Keywords:
barr syndrome;
guillain barr;
associated antigens;
mimicking bacteria ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4422
Abstract: Treatment of high grade serous ovarian cancer (HGSOC) after debulking and chemotherapy remains challenging. This phase 1 trial (NCT04739527) evaluates the use of a cell-based relapse vaccine, DCP-001, to prevent disease recurrence after primary treatment.…
read more here.
Keywords:
cell;
dcp 001;
associated antigens;
vaccine ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-115465
Abstract: Background: Leukemic relapse remains the major cause of treatment failure in hematopoietic stem cell transplant (HSCT) recipients. While the infusion of donor lymphocytes to prevent and treat relapse has been clinically implemented this strategy does…
read more here.
Keywords:
tumor associated;
infusion;
relapse;
cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.17212
Abstract: Previously, we found that most patients with acute myeloid leukemia (AML) expressed at least one of the leukemic associated antigens (LAAs) WT1, survivin and TERT, and different combinations of the three LAAs predicted negative clinical…
read more here.
Keywords:
myeloid leukemia;
antigen;
wt1 survivin;
acute myeloid ... See more keywords